Blood pressure drug recalled nationwide over metal contamination fears

Blood pressure drug recalled nationwide over metal contamination fears · File photo
Blood pressure drug recalled nationwide over metal contamination fears · File photo

Breckenridge Pharmaceutical, Inc. issued a nationwide recall on Monday, November 16, 2026, for one lot of 60mg propranolol hydrochloride extended-release capsules due to potential metal contamination. The medication was distributed nationwide between October 26 and November 4.

  • No adverse health effects were reported as of November 16.
  • The affected medication was packaged in 100-count bottles under the national drug code 51991-817-01.
  • Breckenridge Pharmaceutical notified pharmacies to inspect their current stocks for the recalled product.

No adverse health effects were reported as of November 16. The New Jersey-based company recalled the specific lot, numbered PK25110035, which carries an expiration date of May 2029.

The affected medication was packaged in 100-count bottles under the national drug code 51991-817-01. Wholesalers and retailers received the capsules across the country starting October 26, 2026, through November 4, 2026.

Breckenridge Pharmaceutical notified pharmacies to inspect their current stocks for the recalled product. The capsules were produced by Adare Pharma Solutions, a company based in Pennsylvania.

While Breckenridge Pharmaceutical did not specify how the contamination occurred, the company stated that the capsules involved "shared intermediate material suspected to be the source of metal contamination identified in a separate lot that was not released to market." The pharmaceutical company warned that the potentially contaminated capsules could cause lacerations of soft tissues in the oral cavity, oesophagus, stomach, or intestine.

Despite these risks, the company confirmed that no reports of adverse effects had reached them as of Monday, November 16. Officials urged any patient who experiences such effects to contact a healthcare practitioner immediately and report the incident through the FDA's MedWatch website.

Propranolol capsules are typically prescribed to patients managing high blood pressure. According to the Mayo Clinic and the Cleveland Clinic, the medication is also utilized to treat other conditions, including chest pain, migraines, and tremors.

Patients currently taking this medication should verify their bottle information against the recalled lot number and consult their pharmacist or doctor if they possess the affected capsules.

Related coverage